Alethio raises $90M to target rare blood cancers

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 05 Nov, 08:00 UTC

The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.

science

Sources

• T2Alethio raises $90M to target rare blood cancersBioPharma Dive / Healthcare Dive / MedTech Dive05 Nov, 08:00